Update on cluster headache

Current Opinion in Neurology

Volumn 16, Issue 3, 2003, Pages 333-340

  May, Arne ^a   Leone, Massimo ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Circadian rhythm; Cluster headache; Deep brain stimulation; Genetics; Treatment

Indexed keywords

BOTULINUM TOXIN A; CIS CAPSAICIN; CORTICOSTEROID; ENDOTHELIN; ERGOTAMINE DERIVATIVE; GABAPENTIN; LITHIUM; MELATONIN; METHYSERGIDE; NARATRIPTAN; NEUROPEPTIDE; OXYGEN; SEROTONIN; SUMATRIPTAN; TOPIRAMATE; VALPROATE SEMISODIUM; VERAPAMIL; ZOLMITRIPTAN;

ANALGESIA; BRAIN DEPTH STIMULATION; CIRCADIAN RHYTHM; CLINICAL FEATURE; CLINICAL TRIAL; CLUSTER HEADACHE; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG TOLERABILITY; EPIDEMIOLOGICAL DATA; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HORMONE RELEASE; HUMAN; HYPERBARIC OXYGEN; HYPOTHALAMUS; PERIODICITY; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; REVIEW; SIDE EFFECT;

CLUSTER HEADACHE; ELECTRIC STIMULATION THERAPY; GENOTYPE; HUMANS; HYPOTHALAMUS; PHENOTYPE;

EID: 0038796812     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200306000-00013     Document Type: Review

References (111)

1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8:1-96.
2. Islet H. Episodic cluster headache from a textbook of 1745: Van Swieten's classic description. Cephalalgia 1993; 13:172-174.
3. Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain 1994; 117:427-434.
4. Kunkle EC, Pfieffer J, Wilhoit WM, Hamrick J. Recurrent brief headache in cluster pattern. Trans Am Neurol Assoc 1952; 27:240-243.
5. Ekbom K. Nitroglycerin as a provocative agent in cluster headache. Arch Neurol 1968; 19:487-493.
6. Ekbom K. Patterns of cluster headache with a note on the relations to angina pectoris and peptide ulcer. Acta Neurol Scand 1970; 46:225-237.
7. Kudrow L. The cylic relationship of natural illumination to cluster period frequency. Cephalalgia 1987; 7:76-78.
8. Strittmatter M, Hamann GF, Grauer M, et al. Altered activity of the sympathetic nervous system and changes in the balance of hypophyseal, pituitary and adrenal hormones in patients with cluster headache. Neuro-report 1996; 7:1229-1234.
9. Nelson RF. Testosterone levels in cluster and non-cluster migrainous patients. Headache 1978; 18:265-267.
10. Leone M, Patruno G, Vescovi A, Bussone G. Neuroendocrine dysfunction in cluster headache. Cephalalgia 1990; 10:235-239.
11. Chazot G, Claustrat B, Brun J, et al. A chronobiological study of melatonin, cortisol, growth hormone and prolactin secretion in cluster headache. Cephalalgia 1984; 4:213-220.
12. Ferrari E, Canepari C, Bossolo PA, et al. Changes of biological rhythms in primary headache syndromes. Cephalalgia 1983; 3:58-68.
13. Waldenlind E, Gustafsson SA, Ekbom K, Wetterberg L. Circadian secretion of cortisol and melatonin in cluster headache during active duster periods and remission. J Neurol Neurosurg Psychiatry 1987; 50:207-213.
14. Hofman MA, Zhou JN, Swaab DF. Suprachiasmatic nucleus of the human brain: an immunocytochemical and morphometric analysis. J Comp Neurol 1996; 305:552-556.
15. D'Alessandro R, Gamberini G, Benassi G, et al. Cluster headache in the Republic of San Marino. Cephalalgia 1986; 6:159-162.
16. Ekbom K, Ahlborg B, Schele R. Prevalence of migraine and cluster headache in Swedish men of 18. Headache 1978; 18:9-19.
17. Kudrow L. Cluster headache, mechanism and management, 1st ed. New York: Oxford University Press; 1980.
18. Geweke LO. Misdiagnosis of cluster headache. Curr Pain Headache Rep 2002; 6:76-82.
19. D'Amico D, Rigamonti A, Solari A, et al. Health-related quality of life in patients with cluster headache during active periods. Cephalalgia 2002; 22:818-821.
20. Bahra A, May A, Goadsby PJ, Cluster headache: a prospective clinical study with diagnostic implications. Neurology 2002; 58:354-361. This is a carefully performed prospective epidemiological study, drawing attention to relative delays in diagnosis and undermanagement in clinical practice, as well as clinical characteristics that may aid its better recognition in the future.
21. Ekbom K, Hardebo JE. Cluster headache: aetiology, diagnosis and management. Drugs 2002; 62:61-69. To date the largest epidemiological study reports approximately 554 patients with episodic and chronic cluster headache covering an observation period of more than 30 years.
22. May A, Goadsby PJ. The trigeminovascular system in humans: pathophysiological implications for primary headache syndromes of the neural influences of the cerebral circulation. J Cereb Blood Flow Metab 1999; 19:115-127.
23. May A, Bahra A, Büchel C, et al. PET and MRA findings in cluster headache and MRA in experimental pain. Neurology 2000; 55:1328-1335.
24. Matharu MS, Goadsby PJ. Persistence of attacks of cluster headache after trigeminal nerve root section. Brain 2002; 125:976-984. This highly interesting case report describes a patient with a complete surgical section of the left trigeminal sensory root who continued to have attacks. The excellent discussion describes why the pain and autonomic pathways in cluster headache may be generated primarily from within the brain.
25. Leone M, Attanasio A, Croci D, et al. Neuroendocrinology of cluster headache. Ital J Neurol Sci 1999; 20:S18-S20.
26. Leone M, Russell MB, Rigamoriti A, et al. Increased familial risk of cluster headache. Neurology 2001; 56:1233-1236.
27. Couturier EG, Hering R, Steiner TJ. The first report of cluster headache in identical twins. Neurology 1991; 41:761.
28. Sorensen SA, Araki S. Genetics. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. New York: Raven Press; 1993, pp. 21-27.
29. Sjaastad O, Shen JM, Stovner LJ, Elsas T. Cluster headache in identical twins. Headache 1993; 33:214-217.
30. Russell MB, Andersson PG, Thomsen LL, Iselius L. Cluster headache is an autosomal dominantly inherited disorder in some families: a complex segregation analysis. J Med Genet 1995; 32:954-956.
31. El Amrani M, Ducros A, Boulan P, et al. Familial cluster headache: a series of 186 index patients. Headache 2002; 42:974-977.
32. Lampl C. Childhood-onset cluster headache. Pediatr Neurol 2002; 27:138-140.
33. Evers S, Frese A, Majewski A, et al. Age of onset in cluster headache: the clinical spectrum (three case reports). Cephalalgia 2002; 22:160-162.
34. D'Amico D, Centonze V, Grazzi L, et al. Coexistence of migraine and cluster headache: report of 10 cases and possible pathogenetic implications. Headache 1997; 37:21-25.
35. Haan J, van Vliet JA, Kors EE, et al. No involvement of the calcium channel gene (CACNA1A) in a family with cluster headache. Cephalalgia 2001; 21:959-962.
36. Sjostrand C, Giedratis V, Ekbom K, et al. CACNA1A gene polymorphisms in cluster headache. Cephalalgia 2001; 21:953-958.
37. Sjostrand C, Modin H, Masterman T, et al. Analysis of nitric oxide synthase genes in cluster headache. Cephalalgia 2002; 22:758-764.
38. Shimomura T, Kitano A, Marukawa H, et al. Point mutation in platelet mitochondrial tRNA(Leu(UUR)) in patient with cluster headache. Lancet 1994; 344:625.
39. Seibel P, Grunewald T, Gendolla A, et al. Investigation on the mitochondrial transfer RNA(Leu)(UUR) in blood cells from patients with cluster headache. J Neurol 1996; 243:305-307.
40. Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain 1997; 120:193-209.
41. Dodick D, Rozen T, Goadsby P, Silberstein S. Cluster headache. Cephalalgia 2000; 20:787-803.
42. Goadsby PJ. Short-lasting primary headaches: focus on trigeminal automatic cephalgias and indomethacin-sensitive headaches. Curr Opin Neurol 1999; 12:273-277.
43. Cademartiri C, Torelli P, Cologno D, Manzoni GC. Upper and lower cluster headache: clinical and pathogenetic observations in 608 patients. Headache 2002; 42:630-637.
44. Ekbom K, Kugelberg E. Upper and lower cluster headache (Horton's syndrome). Rome: II Pensiero Scientifico; 1968. pp. 482-489.
45. Pearce JM. Chronic migrainous neuralgia: a variant of cluster headache. Brain 1980; 103:149-159.
46. Manzoni GC, Terzano MG, Bono G, et al. Cluster headache - clinical findings in 180 patients. Cephalalgia 1983; 3:21-30.
47. Boes CJ, Dodick DW. Refining the clinical spectrum of chronic paroxysmal hemicrania: a review of 74 patients. Headache 2002; 42:699-708. A well-written overview on CPH, which outlines that the attack duration appears to be the clinical feature that best distinguishes CPH from other trigeminal autonomic cephalgias (TAC).
48. Kaup A, Mathew N, Levyman C, et al. 'Side locked' migraine and trigeminal autonomic cephalgias: evidence for clinical overlap. Cephalalgia 2003; 23:43-49.
49. Evans RW, Solomon S. Is it migraine or cluster? Headache 2000; 40:694-695.
50. Silberstein SD, Niknam R, Rozen TD, Young WB. Cluster headache with aura. Neurology 2000; 54:219-221.
51. Slow HC, Young WB, Peres MF, et al. Hemiplegic cluster. Headache 2002; 42:136-139.
52. Ko J, Rozen TD. Valsalva-induced cluster: a new subtype of cluster headache. Headache 2002; 42:301-302.
53. Leone M, Rigamonti A, Bussone G. Cluster headache sine headache: two new cases in one family. Cephalalgia 2002; 22:12-14.
54. Vigl M, Zebenholzer K, Wessely P. Cluster headache without autonomic symptoms? Cephalalgia 2001; 21:926-927.
55. Rozen TD. Atypical presentations of cluster headache. Cephalalgia 2002; 22:725-729.
56. D'Amico D, Ferraris A, Leone M, et al. Increased plasma nitrites in migraine and cluster headache patients in interictal period: basal hyperactivity of L-arginine-NO pathway? Cephalalgia 2002; 22:33-36. The findings of this study suggest a basal dysfunction in the L-arginine-nitric oxide pathway in neurovascular headaches. The L-arginine-nitric oxide pathway may be involved in the peripheral mechanisms predisposing individuals with neurovascular headaches to individual attacks.
57. Franceschini R, Tenconi GL, Leandri M, et al. Endothelin-1 plasma levels in cluster headache. Headache 2002; 42:120-124.
58. Nappi G, Sandrini G, Alfonsi E, et al. Impaired circadian rhythmicity of nociceptive reflex threshold in cluster headache. Headache 2002; 42:125-131. The observations in this study led to the conclusion that in cluster headache an impairment of the pain control system exists and that it is probably associated with mechanisms involved in the organization of biological rhythms.
59. Giffin NJ, Goadsby PJ. Basilar artery aneurysm with autonomic features: an interesting pathophysiological problem. J Neurol Neurosurg Psychiatry 2001; 71:805-808.
60. May A, Buchel C, Turner R, Goadsby PJ. Magnetic resonance angiography in facial and other pain: neurovascular mechanisms of trigeminal sensation. J Cereb Blood Flow Metab 2001; 21:1171-1176.
61. Barbanti P, Fabbrini G, Pesare M, et al. Unilateral cranial autonomic symptoms in migraine. Cephalalgia 2002; 22:256-259.
62. Pareja J, Baron M, Gili P, et al. Objective assessment of autonomic signs during triggered first division trigeminal neuralgia. Cephalalgia 2002; 22:251-255.
63. Frese A, Evers S, May A. Autonomic activation in experimental trigeminal pain. Cephalalgia 2003; 23:67-68. The observations in this study underscore the view that autonomic signs are not an exclusive feature of TACs but a secondary and unspecific phenomenon of painful activation of the first trigeminal branch. The pain as such seems to activate a trigeminal-autonomic reflex regardless of whether the pain is a primary headache, a secondary headache, or experimentally induced.
64. Goadsby PJ. Trigeminal autonomic cephalgias (TACs). Acta Neurol Belg 2001; 101:10-19.
65. May A, Büchel C, Bahra A, et al. Intra-cranial vessels in trigeminal transmitted pain: a PET study. Neuroimage 1999; 9:453-460.
66. Hannerz J, Ericson K, Bergstrand G. Orbital phlebography in patients with cluster headache. Cephalalgia 1987; 7:207-211.
67. Moskowitz MA. Cluster headache: evidence for a pathophysiologic focus in the superior pericarotid cavernous sinus plexus. Headache 1988; 28:584-586.
68. May A, Kaube H, Büchel C, et al. Experimental cranial pain elicited by Capsaicin: a PET-study. Pain 1998; 74:61-66.
69. Kaube H, Hoskin KL, Goadsby PJ. Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption. Br J Pharmacol 1993; 109:788-792.
70. Dodick DW, Capobianco DJ. Treatment and management of cluster headache. Curr Pain Headache Rep 2001; 5:83-91.
71. Ekbom K, Monstad I, Prusinski A, et al. Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. The Sumatriptan Cluster Headache Study Group. Acta Neurol Scand 1993; 88:63-69.
72. Wilkinson M, Pfaffenrath V, Schoenen J, et al. Migraine and cluster headache - their management with sumatriptan: a critical review of the current clinical experience. Cephalalgia 1995; 15:337-357.
73. Diener HC. Sumatriptan in the treatment of cluster headache. Cephalalgia 2001; 21:16-17.
74. Hardebo JE, Dahlof C. Sumatriptan nasal spray (20 mg/dose) in the acute treatment of cluster headache. Cephalalgia 1998; 18:487-489.
75. Schuh-Hofer S, Reuter U, Kinze S, et al. Treatment of acute cluster headache with 20 mg sumatriptan nasal spray - an open pilot study. J Neurol 2002; 249:94-99.
76. Bahra A, Gawel MJ, Hardebo JE, et al. Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology 2000; 54:1832-1839.
77. Nilsson Remahl AI, Ansjon R, Lind F, Waldenlind E. Hyperbaric oxygen treatment of active cluster headache: a double-blind placebo-controlled cross-over study. Cephalalgia 2002; 22:730-739. In this very carefully performed, double-blind, placebo-controlled, cross-over study two hyperbaric oxygen sessions were found to be no more effective than two sham treatments in reducing the frequency of attacks or interrupting the cluster headache period.
78. Hering R, Kuritzky A. Sodium valproate in the treatment of cluster headache: an open clinical trial. Cephalalgia 1989; 9:195-198.
79. Wheeler SD, Carrazana EJ. Topiramate-treated cluster headache. Neurology 1999; 53:234-236.
80. Leandri M, Luzzani M, Cruccu G, Gottlieb A. Drug-resistant cluster headache responding to gabapentin: a pilot study. Cephalalgia 2001; 21:744-746.
81. Mulder LJ, Spierings EL. Naratriptan in the preventive treatment of cluster headache. Cephalalgia 2002; 22:815-817.
82. Loder E. Naratriptan in the prophylaxis of cluster headache. Headache 2002; 42:56-57.
83. Saper JR, Klapper J, Mathew NT, et al. Intranasal civamide for the treatment of episodic cluster headaches. Arch Neurol 2002; 59:990-994.
84. Peres MF, Stiles MA, Slow HC, et al. Greater occipital nerve blockade for cluster headache. Cephalalgia 2002; 22:520-522.
85. Gallagher RM, Mueller LL, Freitag FG. Divalproex sodium in the treatment of migraine and cluster headaches. J Am Osteopath Aesoc 2002; 102:92-94.
86. El Amrani M, Massiou H, Bousser MG. A negative trial of sodium valproate in cluster headache: methodological issues. Cephalalgia 2002; 22:205-208.
87. Forderreuther S, Mayer M, Straube A. Treatment of cluster headache with topiramate: effects and side-effects in five patients. Cephalalgia 2002; 22:186-189.
88. Mathew NT, Kailasam J, Meadors L. Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate. Headache 2002; 42:796-803.
89. Leone M, Bussone G. A review of hormonal findings in cluster headache. Evidence for hypothalamic involvement. Cephalalgia 1993; 13:309-317.
90. Leone M, Frediani F, D'Amico D, et al. Dexamethasone suppression test, melatonin and TRH-test in cluster headache. Ital J Neurol Sci 1992; 13:227-232.
91. Ekbom K. Clinical aspects of cluster headache. Headache 1974; 13:176-180.
92. May A, Goadsby PJ. Hypothalamic involvement and activation in cluster headache. Curr Pain Headache Rep 2001; 5:60-66.
93. Pringsheim T. Cluster headache: evidence for a disorder of circadian rhythm and hypothalamic function. Can J Neurol Sci 2002; 29:33-40.
94. Leone M, D'Amico D, Moschiano F, et al. Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia 1996; 16:494-496.
95. Nagtegaal JE, Smits MG, Swart AC, et al. Melatonin-responsive headache in delayed sleep phase syndrome: preliminary observations. Headache 1998; 38:303-307.
96. Peres MF, Rozen TD. Melatonin in the preventive treatment of chronic cluster headache. Cephalalgia 2001; 21:993-995.
97. Pringsheim T, Magnoux E, Dobson CF, et al. Melatonin as adjunctive therapy in the prophylaxis of cluster headache: a pilot study. Headache 2002; 42:787-792.
98. Rollnik JD, Tanneberger O, Schubert M, et al. Treatment of tension-type headache with botulinum toxin type A: a double-blind, placebo-controlled study. Headache 2000; 40:300-305.
99. Schulte-Mattler WJ, Wieser T, Zierz S. Treatment of tension-type headache with botulinum toxin: a pilot study. Eur J Med Res 1999; 4:183-186.
100. Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group. Headache 2000; 40:445-450.
101. Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of tension-type headache. Curr Rev Pain 2000; 4:31-35.
102. Binder WJ, Brin MF, Blitzer A, Pogoda JM. Botulinum toxin type A (BOTOX) for treatment of migraine. Semin Cutan Med Surg 2001; 20:93-100.
103. Evers S, Rahmann A, Vollmer-Haase J, Husstedt IW. Treatment of headache with botulinum toxin A - a review according to evidence-based medicine criteria. Cephalalgia 2002; 22:699-710.
104. Blersch W, Schulte-Mattler WJ, Przywara S, et al. Botulinum toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomized study. J Neurol Sci 2002; 205:59-63. This prospective, double blind, placebo-controlled study in 50 healthy volunteers demonstrates that subcutaneous injection of 100 mouse units of botulinum neurotoxin type A has no genuine peripheral antinociceptive effect.
105. Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995; 1:658-660.
106. Bahra A, Matharu MS, Buchel C, et al. Brainstem activation specific to migraine headache. Lancet 2001; 357:1016-1017.
107. May A, Bahra A, Büchel C, et al. Hypothalamic activation in cluster headache attacks. Lancet 1998; 352:275-278.
108. May A, Ashburner J, Buchel C, et al. Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med 1999; 5:836-838.
109. Matharu MS, Good CD, May A, et al. No change in the structure of the brain in migraine: a voxel-based morphometric study. Eur J Neurol 2003; 10:53-57. The careful discussion in this study suggests that if structural changes are to be found other methods of phenotyping migraine, such as by genotype or perhaps treatment response, may be required.
110. Leone M, Franzini A, Bussone G. Stereotactic stimulation of posterior hypothalamic gray matter in a patient with intractable cluster headache. N Engl J Med 2001; 345:1428-1429. This is the first report on operation in intractable chronic cluster headache patients. When the deep brain stimulator is switched off attacks reappear and disappear when it is turned on again. The method is reversible, the procedure is well tolerated with no relevant side-effects.
111. Leone M, Franzini A, D'Amico A, et al. Preliminary results and follow up of stereotactic electrode implant in posterior hypothalamic gray matter to relieve intractable chronic cluster headache. Neurology 2002; 58:89-90.